Sabby Management’s Viking Therapeutics, Inc. VKTXW Stock Holding History

Sabby Management’s Portfolio VKTXW Stock Details VKTXW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-86,349	Closed	-$39K	–	345
2016 Q4	$39K	Sell	86,349 -30,659	-26%	-$13K	﹤0.01%	287
2016 Q3	$53K	Sell	117,008 -59,105	-34%	-$26K	﹤0.01%	299
2016 Q2	$51K	Buy	+176,113	New	+$65.9K	﹤0.01%	274

Other funds holding VKTXW

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Sabby Management's VKTXW Position: Q1 2017 in Review

Sabby Management sold out of Viking Therapeutics, Inc. (VKTXW) in Q1 2017, closing a stake of 86,349 shares — an estimated $39K sold.

Sabby Management first reported a position in VKTXW in Q2 2016 and held it in 3 quarters. The position peaked at $53K in Q3 2016. 3 funds tracked by Wall St. Rank hold VKTXW as of Q1 2017.

Sabby Management reported no remaining Viking Therapeutics, Inc. position as of Q1 2017 after selling out during the quarter.
Sabby Management sold 86,349 Viking Therapeutics, Inc. shares in Q1 2017, an estimated $39K.
Sabby Management first reported a position in Viking Therapeutics, Inc. in Q2 2016 and held it in 3 quarters.
Sabby Management's Viking Therapeutics, Inc. position peaked at $53K in Q3 2016.
3 funds tracked by Wall St. Rank held Viking Therapeutics, Inc. as of Q1 2017.

Based on Sabby Management's 13F filing for Q1 2017, filed 15 May 2017.